Eliquis, Orencia sales propel Bristol-Myers to strong second quarter

Go back to Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
Bristol-Myers Squibb (NYSE: BMY) Delayed: 60.84 -0.84 (1.36%)
Previous Close $61.68    52 Week High $77.12 
Open $61.50    52 Week Low $49.03 
Day High $61.81    P/E 39.51 
Day Low $60.80    EPS $1.54 
Volume 2,024,064       

Celgene Corp. (NASDAQ: CELG) Delayed: 108.24 --0 (-0%)
Previous Close $108.24    52 Week High $127.00 
Open $7.85    52 Week Low $93.05 
Day High $108.24    P/E 32.12 
Day Low $108.24    EPS $3.37 
Volume 0       

Merck & Co. (NYSE: MRK) Delayed: 148.48 +0.18 (0.12%)
Previous Close $148.30    52 Week High $65.46 
Open $147.11    52 Week Low $47.97 
Day High $149.44    P/E 101.01 
Day Low $147.11    EPS $1.47 
Volume 2,699,955       

Pfizer Inc. (NYSE: PFE) Delayed: 29.76 -0.35 (1.16%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.04 
Day Low $29.73    EPS $1.65 
Volume 6,194,438